Background: Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported.

Case Presentation: In this study, we report a case of cystinuria with xanthine stones and hyperuricemia. The 23-year-old male patient was diagnosed with kidney and ureteral stones, solitary functioning kidney and hyperuricemia after admission to the hospital. The stones were removed by surgery and found to be composed of xanthine.

Conclusion: Genetic testing by next-generation sequencing technology showed that the patient carried the homozygous nonsense mutation c.1113 C> A (p.Tyr371*) in the SLC3A1 gene, which was judged to be a functionally pathogenic variant. Sanger sequencing revealed that the patient's parents carried this heterozygous mutation, which is a pathogenic variant that can cause cystinuria. The 24-h urine metabolism analysis showed that the cystine content was 644 mg (<320 mg/24 h), indicating that the patient had cystinuria, consistent with the genetic test results. This case shows that cystinuria and xanthine stones can occur simultaneously, and provides evidence of a possible connection between the two conditions. Furthermore, our findings demonstrate the potential value of genetic testing using next-generation sequencing to effectively assist in the clinical diagnosis and treatment of patients with urinary calculi.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391995PMC
http://dx.doi.org/10.1186/s12894-023-01300-yDOI Listing

Publication Analysis

Top Keywords

xanthine stones
8
pathogenic variant
8
declaration novel
4
novel slc3a1
4
slc3a1 mutation
4
cystinuria
4
mutation cystinuria
4
cystinuria patient
4
patient xanthine
4
stones
4

Similar Publications

Purpose: Serum uric acid (SUA) is primarily produced through the hydrolysis of purines in the liver, with its excretion largely handled by the kidneys. Urate transporter 1 (URAT1) inhibitors are known to enhance uric acid elimination via the kidneys, but they also increase the risk of kidney stone formation. Currently, xanthine oxidase (XO) inhibitors are the predominant uric-lowering medications on the market.

View Article and Find Full Text PDF

Theobromine for treatment of uric acid stones and other diseases.

Arch Ital Urol Androl

November 2024

C.d.C. Ambrosiana, Cesano Boscone, Milan.

Theobromine (or 3,7-dimethylxanthine) is a natural alkaloid present in cocoa plant and its derivatives, such as chocolate. About 20% of ingested theobromine is excreted unchanged in the urine. Theobromine also derived from caffeine that is metabolized into theobromine by 12%.

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on developing a method to differentiate between pure uric acid stones and other types of urinary stones using computed tomography (CT) imaging.
  • Researchers analyzed clinical data and CT images from patients at a urology department to create a deep learning model that evaluates the chemical composition of stones.
  • The model achieved high accuracy (97.01%) in predicting stone types, demonstrating its potential as a quick and effective diagnostic tool for urinary stone disease.
View Article and Find Full Text PDF
Article Synopsis
  • Bilateral upper urinary tract stones are more likely to cause kidney function issues compared to unilateral stones, and a study analyzed data from 555 patients to explore metabolic differences between these groups.
  • The study found that male patients and those with hyperuricemia had a higher risk of developing bilateral stones, with distinct metabolic abnormalities found, including low urine volume and higher levels of uric acid and creatinine.
  • Results suggest that increasing water intake can help prevent stone formation, especially in patients with elevated uric acid levels.
View Article and Find Full Text PDF

Preparation of matrix-matched calibration standards for accurate determination of elemental concentrations in uric acid stones by LA-ICP-MS.

Anal Methods

January 2025

Research Center of Jiangxi Province for Engineering Technology of Calculus Prevention and Control, Gannan Medical University, Ganzhou 341000, P. R. China.

Accurate determination of elemental concentrations in uric acid (UA) stones is crucial for understanding their formation process. However, the lack of matrix-matched calibration standards has limited the application of laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) in this field. This study addresses this limitation by preparing a synthetic UA precipitate (UA-1) doped with 17 elements using a recrystallization method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!